Status: Recruiting
A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors
The goal of this clinical trial is to learn if the investigational drug (JR8603) is safe and effective in treating patients with solid tumors after their initial rounds of treatment with other drugs did not work.
Participants needed: 94
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: JiaRay GroupUpdated: Sep 9, 2025Locations: 2
Eligibility criteria
≥18 years of age. [+27]
Any condition that in the opinion of the Investigator would place the patient at... [+9]